FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of March 2009
AETERNA ZENTARIS INC.
-----------------------------------
1405, boul. du Parc-Technologique
Quebec, Quebec
Canada, G1P 4P5
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F.
Form 20-F /X/ Form 40-F / /
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934
Yes / / No /X/
If "Yes" is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): 82-____
DOCUMENTS INDEX
Documents Description
--------- -----------
99.1 Material Change Report
99.2 Development, commercialization and license agreement between AEterna
Zentaris GmbH and sanofi-aventis U.S. LLC dated March 5, 2009
99.3 Parent Guarantee between AEterna Zentaris Inc. and
Sanofi-aventis U.S. LLC dated March 5, 2009
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
AETERNA ZENTARIS INC.
Date: March 16, 2009 By: /s/Dennis Turpin
--------------------- ------------------------------------------
Dennis Turpin
Senior Vice President and Chief Financial Officer